BPC-157

BPC-157 is a synthetic peptide sequence frequently referenced in tissue-repair and gut-barrier research. Investigators typically study its behaviour in cell and preclinical models rather than in any applied context. NOX supplies BPC-157 as a lyophilised research reference material for research use only, and none of this information constitutes medical or human-use guidance.

Published research most often examines connective tissues, the gastrointestinal lining and vascular models when characterising BPC-157. These are laboratory and preclinical investigations focused on mechanism and signalling rather than any outcome in humans. The compound is provided purely as a research reference material for research use only.

BPC-157 attracts research attention because it is a stable, well-defined synthetic sequence that is convenient to handle in laboratory models of tissue turnover and repair. Its popularity reflects reproducibility and availability for controlled study rather than any established application. NOX offers it lyophilised for research use only; this text is educational context, not medical guidance.

Lyophilised BPC-157 is supplied as a sealed, freeze-dried powder and is generally kept frozen and away from light, typically stored at around -20°C for long-term stability, while for shorter periods it can be kept in the fridge at 2–8°C. Keeping the vial sealed limits moisture uptake and helps preserve the dry material. This describes general laboratory handling of lyophilised research compounds and is provided for research use only, not as guidance for any other use.

As a sealed, lyophilised powder, BPC-157 is generally stable for extended periods when kept cold and dry, the reason research compounds are supplied freeze-dried rather than in solution. Actual stability depends on storage conditions and handling, so researchers typically record receipt and storage details. This reflects general handling of lyophilised materials and is provided for research use only.

Bacteriostatic water is commonly used to reconstitute lyophilised research compounds because the small amount of benzyl alcohol it contains helps limit microbial growth in a multi-use vial. It simply dissolves the freeze-dried powder into a liquid so the material can be handled in the laboratory. Reconstitution is performed strictly within a research context; BPC-157 is supplied by NOX for research use only.

Once reconstituted, BPC-157 is in solution and generally less stable than the dry powder, so the liquid is typically kept in the fridge at 2–8°C and protected from light. Researchers usually prepare only what a study requires and record the reconstitution date. This reflects general laboratory handling of reconstituted research materials and is offered for research-use-only context, not as guidance for human or veterinary use.

BPC-157 is supplied as a lyophilised powder in 5 mg and 10 mg. The stated strength is the mass of compound sealed in the vial before reconstitution; the working concentration depends on the volume of solvent a researcher adds during preparation. All presentations are research reference materials supplied for research use only.

Yes. BPC-157 is supplied by NOX strictly as a research reference material for laboratory and analytical use. It is not a medicinal product, food, cosmetic or veterinary product, and nothing in these answers should be read as guidance for human or animal use. All information here is provided for educational and research context only.